4D Molecular Therapeutics
FDMT
#7584
Rank
A$0.46 B
Marketcap
$10.08
Share price
9.17%
Change (1 day)
-66.85%
Change (1 year)

Earnings for 4D Molecular Therapeutics (FDMT)

Earnings in 2024 (TTM): -A$0.25 Billion

According to 4D Molecular Therapeutics's latest financial reports the company's current earnings are A$0.01 Million. In 2023 the company made an earning of -A$0.19 Billion a decrease over its 2022 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for 4D Molecular Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.25 Billion38.42%
2023 -A$0.19 Billion2.58%
2022 -A$0.18 Billion54.25%
2021 -A$0.12 Billion25.89%
2020 -A$90.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-19.97%๐Ÿ‡บ๐Ÿ‡ธ USA